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Improving Rural Bone Health and Minimizing
Fracture Risk in West Virginia: Validation of the
World Health Organization FRAX® Assessment
Tool as a Phone Survey for Osteoporosis Detection
administered as a phone survey to 45
patients; these results were compared
to DXA bone mineral density
determination.
Results confirmed that the FRAX®
phone survey is as reliable as DXA in
detecting osteoporosis or clinically
significant osteopenia: 92% positive
predictive value, 100% negative
predictive value, 100% sensitivity and
91% specificity when compared to the
gold standard. These promising results
allow for the development of
telephone-based protocols to improve
osteoporosis detection, referral and
treatment especially in areas with
health care access barriers.
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Abstract
West Virginia ranks second
nationally in population ≥ 65 years old
placing our state at greater risk for
osteoporosis and fracture. The gold
standard for detecting osteoporosis is
dual X-ray absorptiometry (DXA), yet
over half of West Virginia’s counties
do not have this machine. Due to
access barriers, a validated phoneadministered fracture prediction tool
would be beneficial for osteoporosis
screening.
The World Health Organization’s
FRAX® fracture prediction tool was

Introduction
Osteoporosis detection in West
Virginia is limited by resources and
our rural population. West Virginia
is the second most rural state in
the nation with over 67% of our
population living in towns of less
than 2500 people and 50 of our 55
counties federally designated, either
in part or full, as Health Professional
Shortage Areas or Medically
Underserved areas.1-3 Additionally,
16.5% of our population is 65 years
of age or older (second in the
nation).4,5 This large cohort means
that the risk of osteoporosis and
osteoporosis-related fracture, two
age-related conditions, is increased
for West Virginia.6 It is surprising to

note that over a quarter of a million
(77%) of West Virginia’s female
residents over 50 years of age have
osteoporosis or diminished bone
mass.7 Nationally, osteoporosis
remains a public health threat to
almost 55% of the people aged
50 years and older.8 The National
Osteoporosis Foundation (NOF)
estimates that in the United States,
10 million people already have the
disease, while 34 million more are
estimated to have low bone mass,
increasing their risk of fracture.8 In
addition to the personal and local
burden of osteoporosis, there is
also a national burden in terms of
healthcare dollars. Currently, total
costs in the United States are more
than $19 billion dollars and this
number is expected to rise by almost
50% by 2025. These frightening
statistics argue for a low cost, widely
applicable method of screening large
populations in rural areas where
the availability of sophisticated
diagnostic tools such as the dualenergy x-ray absorptiometry
(DXA) scanner is limited.
A DXA scan is considered the
gold standard to assess bone
mineral density (BMD) and detect
osteoporosis.9 By calculating BMD,
physicians are able to evaluate for
osteoporosis, to assess for risk of
fracture, and to monitor response to
treatment. However, in West Virginia,

Objectives
1. To raise awareness about the burden of osteoporosis among elder West Virginians.
2. To examine the validation of the phone based administration of FRAX as an effective, alternative tool for osteoporosis
screening.
3. To consider incorporation of FRAX as an alternative to formal DXA bone mineral density determination to predict those at
greatest risk for fracture facilitating appropriate osteoporosis detection and management in rural populations.
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Figure 1: Map of West Virginia’s 55 counties with highlighted counties
indicating the presence of a free standing DXA unit. 7

Figure 2: The World Health Organization (WHO) fracture prediction tool
(FRAX®).13 Adapted with permission from International Osteoporosis
Foundation, Fracture Risk Assessment Tool Educational Slide-kit.
Available at http://www.iofbonehealth.org/health-professionals/frax.html.

the forefront of an “osteoporosis
epidemic” and effective strategies
need to be developed to better
serve the needs of this population.
This is where FRAX could play
a role in improving access and
detection of osteoporosis.
The World Health Organization
(WHO) has a validated,
internationally accepted fracture
prediction tool -- FRAX®-- which is
used to detect individuals at risk for
fracture. Independent risk factors
of the patient are incorporated
into the FRAX® algorithm and
consist of: country of origin, age,
gender, weight, height, previous
fracture, parental history of hip
fracture, current smoking, use
of glucocorticoids, rheumatoid
arthritis, secondary osteoporosis,
alcohol consumption (3 or more
units/day) and, when available,
BMD at the femoral neck (g/cm2)
obtained by DXA (Figure 2).13 The
algorithm corrects for the different
contributions of each independent
risk factor to yield the ten year
probability of sustaining either a hip
fracture or other major osteoporotic
fracture.13 When the absolute risk
of sustaining a hip fracture within
the next ten years is 3% or above,
or the risk of major orthopaedic
fracture is 20% or above, treatment
is considered cost effective and has
been shown to decrease the rate of
subsequent fractures.14-21 Because
this tool can be used without BMD
data, we hypothesized that FRAX
could be used as a phone screening
tool and would correlate very well
with osteoporosis detection using the
gold standard of BMD using DXA.

Methods

access to DXA scanners is limited,
with the most recent data suggesting
only 24 of 55 counties having a free
standing DXA unit (Figure 1).10 In
addition to limited access, distance
is a factor that negatively impacts

the delivery of rural healthcare.11 A
20% drop in osteoporosis screening
rates occurs when a DXA is located
over 5 miles from a patient.12 This
combination of a rural and aging
population places West Virginia at

www.wvsma.org

This study was IRB approved
(#396973) and involved four
steps: (1) identification of a
pool of rural patients “at risk” for
fracture; (2) randomly contacting
patients to see if they would like
to participate in the research
protocol; (3) obtaining FRAX and
DXA information for each patient
enrolled; and (4) communicating
these results to the patient and
primary care provider (PCP).
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Identification of Patients

We determined the variables used
to screen “at risk” populations in
Marshall Health’s Allscripts EMR
by consulting an expert in the field
of osteoporosis detection and
screening -- Dr. Richard Dell of
Kaiser Permanente. Dr. Dell was
contacted because he uses an EMR
to automatically identify patients
for bone health screenings in their
11-hospital system. Patients were
screened for inclusion by using the
population health management
tool within Allscripts. There were 6
inclusion criteria and 1 exclusion
criteria. Inclusion criteria included
(1) all women 65+ years old; (2) all
men 70+ years old; (3) all patients
over 50 years of age with a fracture
of the proximal humerus, distal
radius, hip or vertebral compression
fracture; (4) patients on 3+ months
of steroids; (5) patients on Lupron;
and (6) including only patients
that live within rural and urban
designations (RUCA’s) consistent
with rural (requirement of the
funding mechanism). Exclusion
criteria included patients already
completing a DXA scan within
the past two years. A total of 572
potential study patients were
identified. From this list, we excluded
patients not living within a rural
RUCA zip code designation.
Contact for Study Participation

From the list of potential study
patients living in rural RUCA’s,
two of the authors (FS, KS)
randomly contacted the patient by
phone to see if they would like to
participate in the research protocol.
A standardized phone discussion
was generated indicating that we
were contacting the patient from
the Department of Orthopaedic
Surgery at Marshall University and
conducting a research study on
weak bones (osteoporosis) and
this study would include a brief 2-3
minute phone conversation and by
participation a free DXA scan would
be arranged at our testing facility.
Response was impressive with
the first 57 phone calls producing
55 people willing to participate.
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Consultation with a statistician was
completed as part of the granting
mechanism and sample size needed
was determined to be n=45.
FRAX and DXA Completion

Fifty-five study patients completed
FRAX with the phone survey taking
an average of two minutes. The
10-year absolute risk of fracture
for the patient was then generated
and recorded and the patient was
immediately notified of their fracture
risk. This information was printed
and mailed to the patient along with
a voucher for a free DXA scan at
the Erma Byrd Clinical Center on
a set date in June or August 2013.
The free voucher was developed in
conjunction with the Senior Services
Division and Cabell Huntington
Hospital Radiology with the study
protocol paying for the DXA scans
with no charges to the study
patients. A total of 45 patients were
able to complete the DXA scans.
Those unable to complete the scans
on the study dates were contacted
by the research team nurse (LM)
and alternative arrangements were
made including a letter sent to their
PCP containing their FRAX data.
Communication of Results

All patients received their FRAX
test results including a professional
interpretation of the DXA scan
(n=45) by an International Society
for Clinical Densitometry (ISCD)
certified endocrinologist (OO).
These results were sent by mail
to the patient and also forwarded
to the participant’s PCP. The
research study nurse’s (LM) phone
number was provided to the study
participants and she assisted with

any questions or interpretations of
the results including coordination
of follow up if needed. A three
month follow up phone call was
completed on all patients (LM).

Results
The total number of patients
completing the study protocol was
45 (June 19, 2013- August 27,
2013). There were 6 males and 39
females. The age range was 52-81
years of age with a mean age of
65.8 years. Results of the FRAX
phone-screening tool and DXA
scan were analyzed by two authors
(TWB, FS). When the absolute
risk of sustaining a hip fracture in
a study participant within the next
ten years was 3% or above, or the
risk of major osteoporosis fracture
was 20% or above, the FRAX
screening was considered positive
for osteoporosis/clinically significant
osteopenia and treatment was
recommended.14-21 FRAX results
demonstrated 25 patients requiring
pharmacological management
(presence of osteoporosis/
clinically significant osteopenia). Of
note, the FRAX scores were recalculated for all participants using
the empirically determined height
and weight data obtained during
DXA scanning. These “corrected”
scores were used in the final data
analysis. For the DXA results,
23 patients were recommended
to receive pharmacological
management (Table 1).
Forty-three of 45 patients had
the CORRECT diagnosis of either
presence or absence of fracture risk
threshold requiring treatment with
100% sensitivity, 91% specificity;
92% positive predictive value

Table 1: Results of DXA Scan versus FRAX Predicted Risk of Fracture
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and 100% negative predictive
value (Table 1). In two patients
FRAX over-predicted the need for
pharmacological management. In
both patients the recommendation
for pharmacological management
was reversed if FRAX was
recalculated using the BMD of the
femoral neck empirically determined
with DXA. For these two patients
additional information is presented.
The first patient was a 77-yearold female with only one FRAX
parameter above threshold -- 3.6%
risk for femoral neck fracture (above
the treatment threshold of 3%).
Using the BMD data this risk was
reduced to 2.1% and was consistent
with the formal DXA reading of no
recommendation for pharmacological
management. The second patient
was a 64-year-old female with two
FRAX parameters above threshold
– 4% risk for femoral neck fracture
and 21% risk of major osteoporotic
fracture (above the treatment
threshold of 20%). Using the BMD
data these risks were reduced
to 2.3% and 16%, both below
thresholds for pharmacological

management and consistent
with the formal DXA reading.
Previously, treatment decisions
for osteoporosis management were
based solely on BMD testing and
T-score generation with previous
publications highlighting that
identical T-scores can produce vastly
different fracture risks.22-24 In this
study cohort, only 10 patients had
a T-score of -2.5 or lower. In the 23
patients with final recommendation
for pharmacological management
for osteoporosis/clinically significant
osteopenia, only 39% (9/23) had
a T-score of -2.5 or lower.
It is worth noting that the threemonth follow-up on all patients
resulted in 100% returning for
further osteoporosis evaluation and
management with their PCP (n=45).

Discussion
In this study, FRAX has been
used and validated as an effective
phone-screening tool to determine
“at risk” populations for osteoporosis/
clinically significant osteopenia.
There was a 4.4% risk (2/45) of

over-prediction of fracture risk
above pharmacological treatment
thresholds using FRAX algorithms
calculated without BMD data. This
risk was reduced to 0% when FRAX
was recalculated using BMD data
obtained from DXA. It is clear from
a recent review that FRAX is useful
for prediction of pharmacological
interventions where facilities for
BMD determination are sparse
like in West Virginia; but BMD
should be used in calculations on
“those close to a probability-based
intervention threshold”.25 In the two
patients where FRAX over-prediction
occurred, both were within 1% of the
threshold value for treatment and in
each, DXA was performed, which
changed the recommendations for
pharmacological management. It is
worth noting that osteoporosis is a
skeletal disorder characterized by
low bone strength and increased
risk of fracture; therefore, treatment
decisions should not be based on
T-score alone. 22 In this study cohort,
the majority (61%) of the study
patients receiving a recommendation
for pharmacological management
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for osteoporosis/clinically
significant osteopenia actually had
T-scores above -2.5 (14/23).
In summary, detection of patients
at greatest risk for fracture is
facilitated by the FRAX tool and can
be easily accomplished by a phone
call with nearly equivalent results to
that of the gold standard DXA scan.
In a state with limited resources
and multiple barriers to health care
access, incorporation of a simple
phone screening tool will help to
improve osteoporosis screening,
detection and treatment which has
been shown to reduce fracture
incidence and the fiscal burden
associated with fracture care.14-21,26,27
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CME Post-Test
21. According to the WV Osteoporosis and Arthritis
Program, how many WV counties have DXA
scanners?
a. 55 counties
b. 40 counties
c. 24 counties
22. The FRAX fracture prediction tool provides an
absolute 10-year risk of hip or major osteoporotic
fracture. Can this tool be used without having BMD
of the femoral neck?
a. Yes
b. No
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23. Current recommendation for treatment of
osteoporosis and clinically significant osteopenia
are based on the risk of fracture. Which strategy
below would provide the most utility at
determination of those greatest at risk for fracture?
a. T score alone
b. Z score alone
c. Physical examination
d. FRAX score (>3% for hip frature and >10% risk
for major osteoporosis fracture)
e. FRAX score (>3% for hip fracture and >20% for
major osteoporosis fracture)
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